Page values for "Mometasone"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Mometasone furoate
brand	`String`	Nasonex (intranasal), Asmanex (inhaled), Elocon (topical), Sinuva (sinus implant); with formoterol as Dulera
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Corticosteroids\|Corticosteroid]] • [[:Category:Glucocorticoids\|Glucocorticoid]] • [[:Category:Inhaled_corticosteroids\|Inhaled corticosteroid (ICS)]]
mechanism	`String`
uses	`String`	'"`UNIQ--vote-00000F98-QINU`"', '"`UNIQ--vote-00000F99-QINU`"', '"`UNIQ--vote-00000F9A-QINU`"', '"`UNIQ--vote-00000F9B-QINU`"'
starting_dose	`String`	Intranasal Nasonex 2 sprays/nostril daily (50 mcg/spray); inhaled Asmanex 220 mcg DPI 1-2 inhalations daily/BID; topical Elocon 0.1% cream daily
preparations	`String`	Nasonex 50 mcg/actuation intranasal; Asmanex HFA MDI 100/200 mcg; Asmanex Twisthaler DPI 110/220 mcg; Elocon 0.1% cream/ointment/lotion; Sinuva sinus implant; Dulera (with formoterol)
fda_max	`String`	Intranasal 200 mcg/d (adults); inhaled 880 mcg/d
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Intranasal • inhaled • topical • intranasal sinus implant
onset	`String`	Intranasal: symptom relief 12-24 hours; inhaled: bronchial effect 1-2 weeks
duration	`String`	24 hours
halflife	`String`	~5 hours (plasma)'"`UNIQ--ref-00000F9C-QINU`"'
bioavailability	`String`	Intranasal: <1% systemic; inhaled lung deposition with extensive first-pass clearance'"`UNIQ--ref-00000F9D-QINU`"'
pregnancy	`String`	Intranasal long considered acceptable; widely used in obstetric rhinitis.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed\|citation needed]]]</sup>
legal	`String`	OTC (Nasonex 24HR) and [[USLegal:Prescription only\|Rx-only]] (other forms) in US